Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
Author(s) -
Citterio Chiara,
Lazzaro Antonio,
Bosi Costanza,
De Ponzio Maurice,
Cavanna Luigi
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4013
Subject(s) - medicine , covid-19 , complication , hematological disorders , hematologic neoplasms , intensive care medicine , cancer , infectious disease (medical specialty) , disease , virology , outbreak
Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom